Avacta Share Discussion Threads

[the stigologist] 23/1/2020 08:31

Super confident Trading Update

Expect they have had some insight from brokers on size/timing of remaining overhang.

Expecting a lot of newsflow to come. Seems to have been serious inflection point in business post LG deal

An inflection point the market ignored because of overhang situation

[purple11] 23/1/2020 08:29

getting quoted 17.55 for just 10000

[escapetohome] 23/1/2020 08:28

Are they stupid? The potential here is 100 bagger.

[dave4545] 23/1/2020 08:06

whoosh 500k volume in 5 mins wow

[dave4545] 23/1/2020 08:03

MM

I'm just saying it's good to know the facts on a stock before buying on a Rns.

Looks like the mm's have decided to play safe and try and clear the overhang at 19p

18p too low 20p+ too high...intraday

[money multipier] 23/1/2020 08:00

Or rather than try a make a few quid today, do you make an investment, hold for a year a see if you've multi bagged on your investment.

[dave4545] 23/1/2020 07:49

They might "intraday" impale a few early on, there is clearly a overhang that needs to be cleared. Price has been very weak. I could buy 150k yesterday near the close around 18p so it's a tricky one, do you chase the mark up or wait for it to come back risking that it might not.

Not my problem but for anybody not in the stock

[bonzo] 23/1/2020 07:42

Look excellent, especially the clinical trial data and sales volume increase.

[dave4545] 23/1/2020 07:36

Quiet here

Think the majority will be very happy with that update.

Now we await the mm's games

[nordic1958] 22/1/2020 14:35

I see Moderna up 7%, market sees a combination of Coronavirus outbreak and Moderna perhaps could be be a player developing a vaccine, considering it is doing the same for CMV, RSV,hMPV/PIV3 ZIKA and influenza H7N9.Ref the MRNA platform and Affimer

[nordic1958] 22/1/2020 09:47

And bulls for good reason.Post JPM healthcare week, very upbeat Tweet from the CEO and his feedback from the Biotech conference meeting new companies and investors and current JV partners.I believe we will have great momentum in the newsflow in Q1.The buyers will be back and you try and pick up more stock at these levels before we have the stock heading north fast!!

[purple11] 22/1/2020 09:08

indeed we were.bulls with no fear.

[dave4545] 21/1/2020 19:47

18p seems to have very strong support and why not, they were piling in upto 20p last Wednesday.

[nordic1958] 21/1/2020 16:20

What is even more interesting, he was prior to his position at Vectura, he was CFO of Immunocore limited, Bill Gates foundation and Astra Zeneca among the shareholders and started his career at GSK!!A board member with several triple A connections.

[the stigologist] 21/1/2020 16:07

Fry is relatively young (early 50s) so this isn't a typical put your feet up retirement NED position

[tromso1] 21/1/2020 16:04

Buying picking up again all of a sudden.

[money multipier] 21/1/2020 16:02

There is no doubt Avacta has huge potential. That’s why I’m here and no doubt why many of the science team and NEDs have joined Avacta. But they have to prove the commercial viability of the science too. Any of the ‘new discussions’ are unlikely to result in deals with cash this year, that’s the reality of this type of business. Deals that are announced shortly are likely to have come out of evaluations that have been ongoing for some time, and without upfront cash are not likely to send the price rocketing. Long term, the JVs and existing deals have huge potential. This year, they need to crack on and get successful results in clinic. The traders will keep telling you it’s about to fly until they’ve sold out. It might or might not, but I’ll be holding out for the trial result and future value.

[bumpa33] 21/1/2020 15:45

Also interesting, Paul Fray holds no other director positions than Vectura, either currently or in the last 5 years. So he’s not one of your ‘serial’ exec guys.

[bumpa33] 21/1/2020 15:36

Current CFO at a £500/600m Pharma joins a £30m minnow. Interesting.

[nordic1958] 21/1/2020 15:10

Think it is important to note the company is talking about many new discussions to follow up in the coming weeks.The oncology sector is attracting a lot of capital and Avacta I am sure will deliver steady news flow that will push the price higher and attract further interest from the majors.The latest JV with Daewoong and the recent news flow from ADC Therapeutics will make Q1 very interesting for Avacta

[purple11] 21/1/2020 14:22

thanks. gl

[money multipier] 21/1/2020 13:43

Purple, from the last fundraising prospectus:
'Avacta expects to file an IND/CTA application by the end of 1Q2020, to dose first patients with AVA6000 Pro-doxorubicin by the end of 2Q2020 with initial read-out expected in 3Q/4Q2020'
Disappointingly is his recent Directors Talk interview Alstair is now saying dosing in H2 with readout late 2020 so a bit more slippage.....

[purple11] 21/1/2020 11:04

well I guess imlocked in here until this latest trial starts.luckilly for me ive the patience to sit it out.
anyone got an idea when it will start?2020 is abit vague.

[bonzo] 21/1/2020 08:53

Paul Fry's appointment will be a big boost to the managing team...